SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-021279
Filing Date
2019-03-25
Accepted
2019-03-25 21:50:11
Documents
2
Period of Report
2019-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3932
2 POA DOCUMENT poa.txt EX-24.4_844319 3630
  Complete submission text file 0001209191-19-021279.txt   8939
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 75 KNEELAND STREET BOSTON MA 02111
Business Address
Loh Evan (Reporting) CIK: 0001622680 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 19703976